Harbour Investments’s Virtus LifeSci Biotech Clinical Trials ETF BBC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-232
| Closed | -$6.48K | – | 3495 |
|
|
2024
Q3 | $6.48K | Sell |
232
-78
| -25% | -$2.18K | ﹤0.01% | 2538 |
|
|
2024
Q2 | $7.83K | Hold |
310
| – | – | ﹤0.01% | 2361 |
|
|
2024
Q1 | $9.03K | Sell |
310
-126
| -29% | -$3.67K | ﹤0.01% | 2265 |
|
|
2023
Q4 | $10.7K | Hold |
436
| – | – | ﹤0.01% | 2120 |
|
|
2023
Q3 | $8.56K | Sell |
436
-303
| -41% | -$5.95K | ﹤0.01% | 2092 |
|
|
2023
Q2 | $17.7K | Hold |
739
| – | – | ﹤0.01% | 1804 |
|
|
2023
Q1 | $16.2K | Hold |
739
| – | – | ﹤0.01% | 1818 |
|
|
2022
Q4 | $18.5K | Sell |
739
-80
| -10% | -$2K | ﹤0.01% | 1714 |
|
|
2022
Q3 | $18K | Hold |
819
| – | – | ﹤0.01% | 1694 |
|
|
2022
Q2 | $18K | Buy |
+819
| New | +$18K | ﹤0.01% | 1694 |
|
|
2021
Q4 | $64K | Sell |
1,654
-2,804
| -63% | -$108K | ﹤0.01% | 1147 |
|
|
2021
Q3 | $204K | Sell |
4,458
-124
| -3% | -$5.67K | 0.01% | 1011 |
|
|
2021
Q2 | $229K | Sell |
4,582
-245
| -5% | -$12.2K | 0.01% | 979 |
|
|
2021
Q1 | $248K | Buy |
+4,827
| New | +$248K | 0.01% | 880 |
|